chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt sick; arm bruises; not being able to feel; neck pain; neck swollen on the side where she got the vaccine; lungs hurt; muscle pain; severe headaches; not receiving 2nd dose on proper time; blood clots on the arm; arm swollen 1-2 weeks after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clots on the arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021c21a and 001c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Oct-2021, the patient experienced THROMBOSIS (blood clots on the arm) (seriousness criterion medically significant). In October 2021, the patient experienced PERIPHERAL SWELLING (arm swollen 1-2 weeks after the 2nd dose). On an unknown date, the patient experienced ILLNESS (felt sick), CONTUSION (arm bruises), SENSORY LOSS (not being able to feel), NECK PAIN (neck pain), SWELLING (neck swollen on the side where she got the vaccine), PULMONARY PAIN (lungs hurt), MYALGIA (muscle pain), HEADACHE (severe headaches) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (not receiving 2nd dose on proper time). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency and METHYLPREDNISOLONE for Muscle pain, at an unspecified dose and frequency. At the time of the report, THROMBOSIS (blood clots on the arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (not receiving 2nd dose on proper time) outcome was unknown and ILLNESS (felt sick), CONTUSION (arm bruises), SENSORY LOSS (not being able to feel), NECK PAIN (neck pain), SWELLING (neck swollen on the side where she got the vaccine), PULMONARY PAIN (lungs hurt), PERIPHERAL SWELLING (arm swollen 1-2 weeks after the 2nd dose), MYALGIA (muscle pain) and HEADACHE (severe headaches) had not resolved.            No concomitant medication details were reported.
2 minutes post flu immunization patient reported light headedness, clammy skin, and fell to the floor.  Patient was unaware of surroundings for approximately 2 minutes. RN monitored vital signs, raised his legs, provided juice and animal crackers. Called 911 after 30 minutes. EMS arrived and took over.  Patient vomited after EMS picked him up and transferred him to the gurney. Patient's wife was notified.
LOSS/ALTERED SENSE OF TASTE; LOSS/ALTERED SENSE OF SMELL; EVERYTHING TASTE LIKE NICKELS; This spontaneous report received from a patient concerned a 21 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the patient experienced loss/altered sense of taste. On 13-MAR-2021, the patient experienced loss/altered sense of smell. On 13-MAR-2021, the patient experienced everything taste like nickels. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from loss/altered sense of taste, loss/altered sense of smell, and everything taste like nickels. This report was non-serious.
Severe Vertigo two days after X2 low grade fever day two days after severe deep tissue muscle pain 5 days after and persists after 2 weeks,  itchiness at injection site lingering two weeks after
the Pfizer BioNtech Covid-19 vaccine gray cap bivalent gives him energy and helps alleviate the fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 62-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "symptoms post Covid" (unspecified if ongoing); "fatigue" (unspecified if ongoing); "neuropathy" (unspecified if ongoing); "didn't have the strength to do anything. He couldn't take a shower without a chair" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed, Unknown Manufacturer), for COVID-19 IMMUNIZATION. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "the Pfizer BioNtech Covid-19 vaccine gray cap bivalent gives him energy and helps alleviate the fatigue".  Additional information: Caller stated her, and her husband were experiencing symptoms post Covid diagnosis and they both feel better after taking the Pfizer BioNtech Covid-19 vaccine gray cap bivalent. Caller reported symptoms experienced by her husband were 62-year-old male experiencing fatigue and neuropathy. Lied on the couch for a month, didn't have the strength to do anything. He couldn't take a shower without a chair and is now on permanent disability. Stated that the Pfizer BioNtech Covid-19 vaccine gray cap bivalent gives him energy and helps alleviate the fatigue. After a few days after taking his booster, he has a lot of energy and feels better for a couple of months.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
3 days post vax 4-5" area of red ten cents to twenty five centss size spots;no blisters;no itch;no streaking;area warm to touch;rx prelone & atarax for sx;
Patient was administered a 4th dose of Gardasil 9 Vaccine that was not needed. Patient had reported to nurse that she had not received vaccine series previously. After vaccine was administered, it was discovered patient had already received the 3 dose vaccine series. Patient was notified regarding extra dose and denies any problems at this time. Patient was monitored for at least 30 minutes post vaccine administration in clinic.
Day 1: limited mobility in the left shoulder join, pain at the injection site Day 3,4,5: numbness of the arm and fingers on the left arm, unable to hold fingers together, whole left arm numbness occasionally, limited control of movements
05-13-2021 tender bumps under the skin of right shin; 05-14-2021 additional bumps on the back of the same leg; 05-15-2021 slight swelling and redness around the bumps; 05-16-2021 increasing redness and swelling; 05-17-2021 additional bumps and redness and swelling on the right leg and small tender bumps starting on left leg; 05-18-2021 redness changes into bruising on both legs and right ankle still swollen; 05-19-2021 seen by urgent care clinic, referred for ultrasound  at home treatments - elevated legs; applied ice packs; foot soaks; aspirin and Advil
BLOOD CLOT IN LUNGS; This spontaneous report received from a consumer via social media  through a company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received vaccination with covid-19 vaccine ad26. cov2. s (Unspecified manufacturer) (suspension for injection, route of admin not reported, and batch number: unknown, expiry: unknown), dose not reported, 1 total, administered on unspecified date for prophylactic vaccination (Dose number in series 1). It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: Unknown, expiry: unknown) dose not reported, 1 total, administered on unspecified date for prophylactic vaccination (Dose number in series 2). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, It was reported that "Our neighbor got his second shot and ended up with blood clots in his lungs." (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot in lungs was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20211254462-covid-19 vaccine ad26.cov2.s-Blood clots in lungs. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Moderna COVID 19 Vacdine EUA Achy skin, broke out in sweat, nausea, fever, headache, trouble sleeping
While giving immunization, started to push med, the needle wasn't completely secure to the syringe, a few drops came out and ran down patient's arm to his pant leg.   Sent text to pharmacy pharmacist on call, states "No additional doses needed!".  Patient started home, turned around and came back.  Upon arrival patient was moved to exam room for privacy.  We then spoke with patient and friend.  They would like an additional dose of the vaccine.  He quoted online research about same situation where patient was given an additional dose.  Advised that we were unable to authorize today and would discuss with appropriate personnel on Monday to get answer. Patient and friend very understanding and appeared satisfied upon leaving.  He is available on Tuesday or Thursday next week for additional does.
Pt vax w/ MMR; 2 weeks after vax was found to be pregnant.  Underwent elective abortion.
vomits; vertigo/spinning; headache; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo/spinning), HEADACHE (headache) and VOMITING (vomits) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE and VITAMINS NOS for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VERTIGO (vertigo/spinning) and HEADACHE (headache). On an unknown date, the patient experienced VOMITING (vomits). At the time of the report, VERTIGO (vertigo/spinning), HEADACHE (headache) and VOMITING (vomits) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo/spinning), HEADACHE (headache) and VOMITING (vomits) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE and VITAMINS NOS for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VERTIGO (vertigo/spinning) and HEADACHE (headache). On an unknown date, the patient experienced VOMITING (vomits). At the time of the report, VERTIGO (vertigo/spinning), HEADACHE (headache) and VOMITING (vomits) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.
1 week after receiving varicella vaccine, patient developed rash on forearm, which spread to chest and back, then regressed into a dermatomal distribution (T1 on Left). Rash consistent with Herpes Zoster, diagnosed on 10/17/07.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On an unknown date the patient was vaccinated with improperly stored PROQUAD (Merck) (dose, strength and frequency not reported, lot # L014401, expiry date: 23-OCT-2016). No adverse effects were reported. This case is one of several cases received from the same source. Additional information has been requested.
throwing up/vomiting; got very sick; This is a spontaneous report from a contactable consumer. An 88-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 21Jan2021 to 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient reported that she was taking unspecified concomitant medications. On 21Jan2021 at 11:30, the patient got very sick, throwing up/vomiting and it lasted about 3 and a half hours until 3 or 3:30 or 4. The patient took Zofran to s top throwing up. The outcome oft he events was recovered on21Jan2021. The next dose is scheduled on 11Feb2021.  Information about lot and batch number was requested.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 injection (lot # M029680, expiration date 17-JAN-2018; lot # M038359, expiration date: 13-MAY-2018; lot # M036728, expiration date: 20-MAY-2018; dose and route of administration were not provided). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of above 46 but below 77 degrees Fahrenheit for 40 minutes. Digital data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA006072: US-009507513-1701USA012827: US-009507513-1702USA006071.
tongue stinging; face stinging; back arms stinging; bottom stinging; back stinging; seeing black dots in her right eye; legs itiching; dizzy; burning sensation felt like she fell into a beehive; stinging sensation felt like she fell into a bee hive; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Mar-2021 and was forwarded to Moderna on 25-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation felt like she fell into a beehive), PAIN (stinging sensation felt like she fell into a bee hive), GLOSSODYNIA (tongue stinging), PAIN (face stinging) and PAIN (back arms stinging) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Acid reflux (oesophageal), Respiratory abnormality, unspecified since an unknown date, Thyroid disorder since an unknown date and Asthma. Concomitant products included LOSARTAN, PRAVASTATIN and FAMOTIDINE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced BURNING SENSATION (burning sensation felt like she fell into a beehive) and PAIN (stinging sensation felt like she fell into a bee hive). On 19-Mar-2021, the patient experienced EYE DISORDER (seeing black dots in her right eye), PRURITUS (legs itiching) and DIZZINESS (dizzy). On an unknown date, the patient experienced GLOSSODYNIA (tongue stinging), PAIN (face stinging), PAIN (back arms stinging), PAIN (bottom stinging) and PAIN (back stinging). At the time of the report, BURNING SENSATION (burning sensation felt like she fell into a beehive) and PAIN (stinging sensation felt like she fell into a bee hive) had not resolved and GLOSSODYNIA (tongue stinging), PAIN (face stinging), PAIN (back arms stinging), PAIN (bottom stinging), PAIN (back stinging), EYE DISORDER (seeing black dots in her right eye), PRURITUS (legs itiching) and DIZZINESS (dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, on 19-Mar-2021, patient's blood pressure went up (details not provided) and she had to increase her blood pressure medicine.   Treatment  information was not provided.
Varicella vaccination 4/27/16 at 0900 and next day at about 1700 noticed reddened, raised area at site of injection. Some discomfort and some itching.
Fever; Night time Chills; Received 3 Moderna Covid-19 vaccinations; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (Received 3 Moderna Covid-19 vaccinations), CHILLS (Night time Chills) and PYREXIA (Fever) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A, 016M20A and 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis (Left shoulder and right foot).   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 30-Dec-2020,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INCORRECT DOSE ADMINISTERED (Received 3 Moderna Covid-19 vaccinations). On 04-Feb-2021, the patient experienced CHILLS (Night time Chills). On 05-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, INCORRECT DOSE ADMINISTERED (Received 3 Moderna Covid-19 vaccinations), CHILLS (Night time Chills) and PYREXIA (Fever) had resolved. Not Provided          No concomitant medications were provided by the reporter.    Patient reported that his chronically swollen right fingers, left shoulder arthritis, right foot arthritis were all gone and feeling better after second shot of the vaccine. Treatment information was not provided.   This case was linked to MOD-2021-048730 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Additional information received
5/27/08 Per mom developed (1) lesion on shoulder area, some itchiness noted. New lesions < 12 developed papular, pustular rash on trunk and extremities; some areas crusted on exam 6/2/08. Diagnosed with varicella infection; comfort measures reviewed.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/5/2023 ASTHMA, UNSPECIFIED
Pt recvd 1st dose of Hep B vax between OCT86 & APR87; recvd 2nd dose AUG87 & dose of Engerix-B JAN92 & did not respond; will receive booster;
Large red rash (2"x3") on left forearm, looks swollen, is painful, not itchy. Received 2 vaccinations on 10/4, came back to pharmacy on 10/7. Advised patient to take NSAID for inflammation and pain and report back tomorrow if not better.
Patient stated roughly about 4 hours after vaccination, she felt very tired. She experienced achiness around the injection site, felt warmth, and redness radiating from injection site down her arm passed elbow. She slept for 4 hours and took OTC Ibuprofen around the clock for 4-5 days. Symptoms subsided after ~5 days
Burning  sensation of skin on arms, shoulders, back, neck, lower face lower back.  Skin feels like radiating heat towards clothes or blanket. sweating and chills while sleeping. no fever or abnormal temperature when checked with oral thermometer. skin still sensitive.
0950 Dizziness VSBp 13378, HR 65, says 99%resp 18. 1006 Dizziness resolved
Patient had COVID vaccination on 2/3 with no adverse s/s before leaving unit.  Upon coming to treatment Friday 2/5 he reported to the RN that he had fallen on thursday 2/4 due to "getting up fast"  did not hit head or hurt anything per RN discussion.  Began treatment without difficulty.  About 3/4 way through treatment was  talking with staff and became unresponsive - code was called and pt expired after 30 minute resuscitation efforts.
after receiving vaccine pt felt dizzy and fainted mom caught her in her arms and lowered her to floor pt did not hit head or other parts of body pt gained conscious with in 2-3 seconds no c/o headache or dizziness took to medical tent gave OJ felt a lot better  vital signs normal pt monitored 30 mins mom at bedside, pt also stated she's on her menstrual cycle
breakthrough Covid case; breakthrough Covid case; This is a spontaneous report from a contactable consumer or other non hcp.    A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications was not reported. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, at single dose for covid-19 immunisation. It was reported that, patient received both doses of Pfizer vaccine (Further not clarified hence captured as Unspecified vaccine) a few months ago and just wanted to call because recently patient had a breakthrough Covid case. It was reported as there was product complaint. The lab tests included test : covid-19, result: positive on unknown date. The outcome of the events was unknown. ~ Follow-up(12Jun2021): Upon follow up, no new information was included.  Information on Lot/Batch number has been requested.
Parents state that child developed a rash to both upper legs that lasted for about 2 weeks. The rash didn't seem to bother him. Just red and raised. Did not happen at the 2 month vaccine visit.
"Pt w/ allergies to Peanut and Nut Flavor (N/V for both).  Pt has a hx of vasovagal syncope/syncope, and Asthma.  Pt received first dose of Pfizer 06/12/2021 at 9:59 am. While waiting and sitting on a chair under observation around 10:06am, pt had an episode of syncope and her lips appeared pale. No fall occurred. Pt was alert and oriented right after. Ambulated to triage via wheelchair. Charge RN/onsite provider/ANM was notified.    VSS: 105/66 (BP), 18 (RR), 72 (HR), 98% spo2 at 10:08am.  101/67 (BP), 24 (RR), 69 (HR), 100% spo2 at 10:30 am. As per mom, pt has a hx of syncope. Our onsite provider advised pt to see her primary care doctor on Monday. Pt was D/C with family to home around 10:30am via wheelchair. Pt was advised to see emergency services if symptoms worsen."